Search research articles
Contact Us
Filters
Showing results (251-260 of 285) with videos related to
Page
of 29
Sort By:
Journal of Medicinal Chemistry
|
March 21, 2020
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds
Irene G Salado, Abhimanyu K Singh, Carlos Moreno-Cinos, et al.
Molecular Pharmacology
|
November 29, 2025
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840
Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, et al.
Archiv Der Pharmazie
|
October 30, 2022
SAR exploration of the non-imidazole histamine H<sub>3</sub> receptor ligand ZEL-H16 reveals potent inverse agonism
Gábor Wágner, Tamara A M Mocking, Xiaoyuan Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2010
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jähnichen, Christophe Blanchetot, David Maussang, et al.
The Journal of Biological Chemistry
|
January 24, 2004
Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity
Paul J Hensbergen, Dennis Verzijl, Crina I A Balog, et al.
RSC Medicinal Chemistry
|
February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H<sub>1</sub> receptor
Tom Dekker, Oscar P J van Linden, Herman D Lim, et al.
Analytical Chemistry
|
December 2, 2010
Nanofractionation spotter technology for rapid contactless and high-resolution deposition of LC eluent for further off-line analysis
Jeroen Kool, Gerdien de Kloe, Arnoud D Denker, et al.
The Journal of Clinical Investigation
|
October 28, 2010
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice
Gerold Bongers, David Maussang, Luciana R Muniz, et al.
Pain
|
February 15, 2011
Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic
Lindsay B Hough, Julia W Nalwalk, Jun Yang, et al.
Chemmedchem
|
August 28, 2024
The Role of Water Networks in Phosphodiesterase Inhibitor Dissociation and Kinetic Selectivity
Antoni R Blaazer, Abhimanyu K Singh, Lorena Zara, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 285) with videos related to
Sort By:
Page
of 29
Journal of Medicinal Chemistry
|
March 21, 2020
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds
Irene G Salado, Abhimanyu K Singh, Carlos Moreno-Cinos, et al.
Molecular Pharmacology
|
November 29, 2025
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840
Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, et al.
Archiv Der Pharmazie
|
October 30, 2022
SAR exploration of the non-imidazole histamine H<sub>3</sub> receptor ligand ZEL-H16 reveals potent inverse agonism
Gábor Wágner, Tamara A M Mocking, Xiaoyuan Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2010
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jähnichen, Christophe Blanchetot, David Maussang, et al.
The Journal of Biological Chemistry
|
January 24, 2004
Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity
Paul J Hensbergen, Dennis Verzijl, Crina I A Balog, et al.
RSC Medicinal Chemistry
|
February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H<sub>1</sub> receptor
Tom Dekker, Oscar P J van Linden, Herman D Lim, et al.
Analytical Chemistry
|
December 2, 2010
Nanofractionation spotter technology for rapid contactless and high-resolution deposition of LC eluent for further off-line analysis
Jeroen Kool, Gerdien de Kloe, Arnoud D Denker, et al.
The Journal of Clinical Investigation
|
October 28, 2010
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice
Gerold Bongers, David Maussang, Luciana R Muniz, et al.
Pain
|
February 15, 2011
Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic
Lindsay B Hough, Julia W Nalwalk, Jun Yang, et al.
Chemmedchem
|
August 28, 2024
The Role of Water Networks in Phosphodiesterase Inhibitor Dissociation and Kinetic Selectivity
Antoni R Blaazer, Abhimanyu K Singh, Lorena Zara, et al.
Page
of 29